In today’s recent session, 1.72 million shares of the Alterity Therapeutics Ltd ADR (NASDAQ:ATHE) have been traded, and its beta is 0.73. Most recently the company’s share price was $5.65, and it changed around -$0.9 or -13.74% from the last close, which brings the market valuation of the company to $86.73M. ATHE at last check was trading at a discount to its 52-week high of $7.00, offering almost -23.89% off that amount. The share price’s 52-week low was $1.00, which indicates that the recent value has risen by an impressive 82.3% since then. We note from Alterity Therapeutics Ltd ADR’s average daily trading volume that its 10-day average is 0.12 million shares, with the 3-month average coming to 70.88K.
Alterity Therapeutics Ltd ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended ATHE as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Alterity Therapeutics Ltd ADR is expected to report earnings per share of 0 for the current quarter.
Alterity Therapeutics Ltd ADR (NASDAQ:ATHE) trade information
Instantly ATHE has been showing red trend so far today with a performance of -13.74% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 7.00 on recent trading dayincreased the stock’s daily price by 19.29%. The company’s shares are currently up 197.37% year-to-date, but still up 15.31% over the last five days. On the other hand, Alterity Therapeutics Ltd ADR (NASDAQ:ATHE) is 44.13% up in the 30-day period. We can see from the shorts that 0.16 million shares have been sold at a short interest cover period of 2.38 day(s).
Alterity Therapeutics Ltd ADR (ATHE) estimates and forecasts
The year-over-year growth rate is expected to be -20.77%, down from the previous year.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 24.86%.
ATHE Dividends
Alterity Therapeutics Ltd ADR’s next quarterly earnings report is expected to be released in August.
Alterity Therapeutics Ltd ADR (NASDAQ:ATHE)’s Major holders
Upon looking at major shareholders, 1.45% of them are in the hands of institutional investors. The stock currently has a share float of 1.45%. Alterity Therapeutics Ltd ADR stock is held by 15.0 institutions, with MORGAN STANLEY being the largest institutional investor. By 2024-06-30, it held 0.0013% of the shares, which is about 48395.0 shares worth $87595.0.
SUSQUEHANNA INTERNATIONAL GROUP, LLP, with 0.0006% or 23311.0 shares worth $41960.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
The former held 1.16 shares worth $6571.0, making up 0.01% of all outstanding shares.
